Targeted RNA Sequencing Market Overview:
The Targeted RNA Sequencing Market has demonstrated noteworthy growth, propelled by a rising demand for accurate and efficient RNA molecule analysis. Positioned as an advanced molecular biology technique, targeted RNA sequencing empowers researchers to concentrate on specific RNA sequences of interest, delivering a cost-effective and information-rich alternative to conventional methods. Targeted RNA Sequencing Market was USD 4,554.59 million in 2022 It is projected to reach USD 8,684.17 million by 2030, indicating a CAGR of 8.5% during the forecast period.
Market Key Drivers:
The robust Growth of The Targeted RNA Sequencing Market is underpinned by several key drivers. There is a discernible uptick in the importance placed on comprehending gene expression patterns, splicing variants, and RNA modifications. The method’s capacity to provide valuable insights into disease mechanisms, biomarker identification, and the facilitation of targeted therapeutics development has driven its widespread adoption in both academic and clinical settings.
Market Segmentation:
Targeted RNA Sequencing Market can be segmented By Technology (Exome Sequencing, Enrichment Sequencing, and Amplicon Sequencing), By Application (Biomedical Research, Plant & Animal Sciences, Drug Discovery, and Others), By End-User (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)
Top Key Players in the Targeted RNA Sequencing Market:
· Roche Holdings
· Thermo Fisher Scientific
· Illumina Inc.
· Agilent Technologies
· Oxford Nanopore Technologies
· DNASTAR Inc.
· QIAGEN
· BGI
· Bio-Rad Laboratories Inc.
· PierianDx
Regional Analysis:
The foremost share contribution to market growth was observed in North America, attributed to the substantial presence of key healthcare research entities and a well-established healthcare industry. The growth in this region is propelled by escalating investments in initiatives focusing on new drug development, the expansion of hospital facilities, and other pertinent factors. Notably, technological advancements and the heightened demand for innovative drugs are acting as catalysts for market expansion in North America. This dynamic confluence of factors underscores the region’s pivotal role in shaping and driving the growth trajectory of the market.
About Us:
Consegic Business Intelligence Pvt Ltd. is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domains. The industry provides consulting services, syndicated research reports, and customized research reports.
Topnotch research organizations and institutions to comprehend the regional and global commercial status use the data produced by Consegic Business Intelligence Pvt Ltd. Our reports comprise in-depth analytical and statistical analysis on various industries in foremost countries around the globe.
Contact us:
Consegic Business intelligence Pvt Ltd.
Contact no: (US) (505) 715-4344
Email: [email protected]
About Author
